GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: CVT-303 | Ranexa® | RS-43285 | RS-43285-003
ranolazine is an approved drug (FDA (2006), EMA (2008))
Compound class:
Synthetic organic
Comment: The mechanism of action of ranolazine is largely unknown, but may have some antianginal effects by inhibition of the late sodium current in cardiac cells.
View more information in the IUPHAR Pharmacology Education Project: ranolazine |
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. El-Bizri N, Kahlig KM, Shyrock JC, George Jr AL, Belardinelli L, Rajamani S. (2011)
Ranolazine block of human Na v 1.4 sodium channels and paramyotonia congenita mutants. Channels (Austin), 5 (2): 161-72. [PMID:21317558] |